Key takeaways
- Daily medicines can treat anxiety without depression. SSRI or SNRI benefit is assessed over weeks, not after a single tablet. ACE
- Faster relief does not establish better long-term treatment. Benzodiazepines are not routine first-line medicines for generalised anxiety or routine long-term treatment for panic disorder. ACE, NICE
- Early side effects and other health risks need review. Alcohol, opioids, driving, pregnancy, bipolar symptoms and thoughts of self-harm all affect safety. HealthHub
Anxiety medicines: daily treatment versus short-term relief
ACE gives 4-8 weeks for a usual SSRI or SNRI trial in generalised anxiety disorder. For benzodiazepines prescribed for severe acute anxiety, it aims for short-term use of up to 2-4 weeks, with the shortest effective duration. Sedation, poor coordination, tolerance, dependence and withdrawal are reasons for this restriction. A review must establish what the medicine is treating and whether continued use is appropriate. ACE
Why does “fast-acting” not mean “stronger”?
A daily medicine addresses ongoing anxiety and impaired functioning; short-term relief addresses acute distress or a specific symptom. Singapore’s Agency for Care Effectiveness (ACE) guideline, updated 29 July 2026, covers adults aged 18 and above with generalised anxiety disorder (GAD). Its recommendations vary with severity: CBT-based therapy is preferred for mild GAD, either CBT-based therapy or an SSRI/SNRI can be offered for moderate GAD, and a combination is first-line for severe GAD. ACE
For first-line SSRI or SNRI treatment, ACE gives 4-8 weeks as a usual adequate trial, with longer needed for some people. Early increases in anxiety can occur. Its review process checks adherence, adverse effects and possible reasons for poor response before changing treatment. Specialist involvement is advised after two unsuccessful trials, or earlier for worsening symptoms or tolerability problems. Neither one or two doses nor immediate sedation establishes the eventual benefit.
| Medicine role | Typical question it answers | Important limitation |
|---|---|---|
| Daily SSRI or SNRI | Is the overall anxiety pattern and daily functioning improving over an adequate trial? | Benefit develops gradually; early adverse effects and withdrawal need a plan |
| Short-term benzodiazepine | Is there a clinician-defined temporary role for severe acute anxiety? | Sedation, impaired coordination, tolerance, dependence and withdrawal restrict use |
| Other symptom-targeted medicine | Is one physical or short-lived symptom being treated for a specific reason? | It may not treat the wider anxiety disorder and may still impair alertness or interact |
| Psychological treatment | Are thoughts, avoidance and responses being addressed with a structured method? | It requires a suitable approach, participation and time; medicine is not a substitute for every therapy goal |
What do daily SSRI and SNRI medicines do?
SSRIs and SNRIs have anxiety indications as well as depression uses. Selective serotonin reuptake inhibitors (SSRIs) such as escitalopram and sertraline, and serotonin-noradrenaline reuptake inhibitors (SNRIs) such as venlafaxine, are antidepressant classes that also have anxiety indications. The class name does not mean depression must be present.
The current ACE guidance says medicine choice depends on medical history, other medicines, adverse-effect risk and kidney or liver function. Common discussion points include nausea, dizziness, restlessness, sleep changes, appetite or weight changes and sexual effects; SNRIs may also raise heart rate or blood pressure. The HealthHub escitalopram guide also notes that full benefit takes a few weeks and lists mood changes, mania, low sodium, bleeding and serotonin syndrome among concerns needing clinical attention.
HealthHub says to take escitalopram with or after food, regularly rather than only on stressful days, and to continue after improvement. Do not stop or alter it without the doctor. Missed doses can resemble returning anxiety; follow the label or ask the pharmacist, without doubling. The guide specifically asks about St John’s wort, traditional remedies and other antidepressants taken in the past 2 weeks because interactions can be serious. HealthHub
Where do short-term medicines fit?
Benzodiazepines may have a carefully assessed short-term role in severe acute anxiety. Their effect starts sooner than with SSRIs or SNRIs. ACE advises against routinely using them as first-line treatment for generalised anxiety disorder. It allows a carefully assessed short-term role for severe acute anxiety, with attention to daytime sedation, cognition, respiratory disease, alcohol, opioids, other sedatives and a history of substance misuse.
That limited role should not be extended to every anxiety diagnosis. NICE guidance states that benzodiazepines should not be used as the long-term medicine treatment for panic disorder because longer-term outcomes are poorer. Panic disorder, generalised anxiety and a single performance situation therefore cannot be treated as interchangeable labels.
ACE names hydroxyzine as an option for some mild GAD or as an adjunct, with excessive sleepiness, anticholinergic effects and possible QTc interval prolongation, an electrical heart-rhythm risk. ACE
Other medicines may sometimes be used for a narrow symptom or circumstance. A sedating antihistamine may cause substantial sleepiness; a beta blocker such as propranolol may be considered off-label for selected physical symptoms, but does not treat every cognitive or avoidance feature of anxiety. These are not casual substitutes for a diagnosis-specific plan.
What should be checked in the first few weeks?
Record changes in both symptoms and everyday functioning. ACE names the Generalised Anxiety Disorder 7-item (GAD-7) scale for symptom monitoring. Its additional functioning question, or the WHO Disability Assessment Schedule 2.0, can track difficulties in daily life. Agreed goals may include less time lost to worry, less avoidance, better sleep, improved work or study and fewer panic episodes. ACE
SSRIs and SNRIs can initially cause restlessness, sleep disruption, nausea or increased anxiety. ACE advises close monitoring for new suicidal thoughts or behaviour during the early months and after dose changes, especially in people under 25 or with existing suicide risk. New agitation, unusually elevated or irritable mood, very little need for sleep, impulsive behaviour or rapidly worsening distress needs prompt review because it may change the diagnosis and treatment.
Do not use alcohol to counter early activation or use another person’s sedative to sleep. Alcohol, opioids and sedating medicines can compound drowsiness and breathing risk. Until the individual effect is clear, driving, cycling in traffic, working at height and operating machinery need particular caution.
Why does stopping need its own plan?
Both daily antidepressants and benzodiazepines need an agreed stopping plan. Their withdrawal risks differ; an online comparison cannot decide the change. Dizziness, nausea, sleep disturbance, anxiety, unusual sensations and irritability can follow missed doses or rapid reduction of an antidepressant. Benzodiazepine withdrawal can be serious, particularly after regular use.
ACE recommends continuing an effective SSRI or SNRI for at least six months after remission. At a stopping review, previous relapses, adverse effects, current stressors, other mental health conditions, family support and personal preference all matter. Gradual reduction is recommended when discontinuation is agreed. ACE describes electric sensations and depersonalisation, alongside dizziness, within hours or days of reducing or stopping. Difficulty reducing a benzodiazepine warrants review. A taper copied from someone else cannot account for these differences. ACE
What changes the answer?
Diagnosis, therapy options, health history and impairment risks affect the plan.
- The diagnosis and severity. Generalised anxiety, panic disorder, social anxiety, trauma-related symptoms, obsessive-compulsive disorder and anxiety caused by another condition do not have one medicine algorithm.
- Psychological treatment. CBT-based approaches are first-line or co-first-line in many anxiety settings and may address avoidance and coping patterns that a tablet does not.
- Bipolar disorder or mania history. Antidepressant treatment requires a different assessment when past periods of elevated mood, reduced need for sleep or impulsivity suggest bipolarity.
- Alcohol, opioids and sedatives. These materially change impairment, overdose and breathing risks.
- Pregnancy, breastfeeding, age and organ function. These affect medicine choice, exposure and monitoring.
- Driving and safety-critical work. Sedation, slowed reaction and impaired coordination may be decisive even if anxiety improves.
When is urgent help needed?
Seek urgent medical assessment for thoughts of suicide or self-harm or inability to stay safe. Other urgent signs include severe agitation or confusion, a suspected overdose, collapse, seizure, severe breathing difficulty, or signs of serotonin syndrome such as fever with marked agitation, confusion and uncontrolled muscle movements.
995 is the emergency number in Singapore for immediate danger. For 24-hour support, HealthHub MindSG lists 1771 for national mindline and 1767 for Samaritans of Singapore. Its helpline panel also offers national mindline chat on 6669-1771 and links to SOS CareText. Outside Singapore, use local emergency and crisis services. MindSG
Bring all medicines, supplements and traditional remedies to a routine review, with a record of daily symptoms and short episodes. The mental-health category and generalised-anxiety condition page explain terminology for that discussion.
Sources
- Singapore Agency for Care Effectiveness: Generalised anxiety disorder: easing burden and enabling remission.
- HealthHub Singapore: Escitalopram medicine guide.
- NICE: Generalised anxiety disorder and panic disorder in adults: recommendations.
- HealthHub MindSG: Preventing self-harm and suicide: helplines.
- Samaritans of Singapore: 24-hour support services.
